James Patrick Kelly

Insider Reports History

Entity
Individual
Location
C/O Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD
Signature
/s/Mark J. Casey, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Patrick Kelly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NOVAVAX INC EVP, CFO and Treasurer Common Stock 14.4K $187K $12.96 Aug 16, 2024 Direct
NOVAVAX INC EVP, CFO and Treasurer Restricted Stock Units 0 $0 $14.09 Aug 16, 2024 Direct

Insider Reports Filed by James Patrick Kelly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NVAX NOVAVAX INC Aug 16, 2024 3 $14.8K 4 Aug 20, 2024 EVP, CFO and Treasurer
NVAX NOVAVAX INC Mar 10, 2024 3 -$12.1K 4 Mar 12, 2024 EVP, CFO and Treasurer
NVAX NOVAVAX INC Mar 1, 2024 1 $0 4 Mar 26, 2024 EVP, CFO & Treasurer
NVAX NOVAVAX INC Sep 12, 2023 4 -$33.1K 4 Mar 11, 2024 EVP, CFO and Treasurer
NVAX NOVAVAX INC Aug 16, 2023 3 -$8.15K 4 Aug 18, 2023 EVP, CFO and Treasurer
NVAX NOVAVAX INC Mar 10, 2023 3 $13.9K 4 Mar 14, 2023 EVP, CFO and Treasurer
NVAX NOVAVAX INC Mar 7, 2023 2 $0 4 Mar 9, 2023 EVP, CFO and Treasurer
NVAX NOVAVAX INC Aug 16, 2022 3 -$49.1K 4 Aug 18, 2022 EVP, CFO and Treasurer
NVAX NOVAVAX INC Mar 10, 2022 2 $0 4 Mar 14, 2022 EVP, CFO and Treasurer
NVAX NOVAVAX INC Aug 16, 2021 2 $0 4 Aug 18, 2021 EVP, CFO and Treasurer
NVAX NOVAVAX INC Aug 16, 2021 0 $0 3 Aug 18, 2021 EVP, CFO and Treasurer